Key facts
- This page summarizes David Young's Form 4/A - Amendment filing for Processa Pharmaceuticals, Inc. (PCSA).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Feb 2025, 17:57.
David Young - 27 Jan 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)
- Reporting relationship
- Pres. Research & Development, Director
- Issuer ticker
- PCSA
- Reported as of
- 27 Jan 2025
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 18 Feb 2025, 17:57:28 UTC
- Original report date
- 29 Jan 2025
- Prior SEC filing
- 02 Aug 2024
- Next SEC filing
- 11 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
David Young filed Form 4/A - Amendment for Processa Pharmaceuticals, Inc. (PCSA) on 18 Feb 2025.
Change
- Previous filing in this sequence was filed on 02 Aug 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 205,405
- Date
- 27 Jan 2025
- Ownership
- Direct
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 30,985
- Date
- 27 Jan 2025
- Ownership
- By Young-Plaisance Revocable Trust
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,786
- Date
- 27 Jan 2025
- Ownership
- By Family Entities
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,544
- Date
- 27 Jan 2025
- Ownership
- By CorLyst, LLC
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCSA
transaction
Derivative
Warrants
Award
- Transaction value
- $0
- Shares
- +124,500
- Change %
- Price
- $0.000000
- Shares after
- 124,500
- Date
- 29 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 124,500
- Exercise price
- $0.6500
PCSA
transaction
Derivative
Warrants
Award
- Transaction value
- $0
- Shares
- +62,250
- Change %
- Price
- $0.000000
- Shares after
- 62,250
- Date
- 29 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 62,250
- Exercise price
- $0.6500
* marks a reported price that did not pass the local price check.